Behandling af diabetes mellitus med biologiske laegemidler.
Research output: Contribution to journal › Journal article › Research › peer-review
Biologic therapeutics are currently not approved for the treatment of patients with type 1 and type 2 diabetes. However, promising results from recent randomized controlled studies suggest that biologic therapeutics have therapeutic potential. This article summarizes the causal steps of the pathogenesis of type 1 and type 2 diabetes which are targeted by biologic therapeutics and reviews the treatment results.
Udgivelsesdato: 2008-Jun-9
Udgivelsesdato: 2008-Jun-9
| Translated title of the contribution | Treatment of diabetes mellitus with biologic therapeutics |
|---|---|
| Original language | Danish |
| Journal | Ugeskrift for læger |
| Volume | 170 |
| Issue number | 24 |
| Pages (from-to) | 2134-7 |
| Number of pages | 3 |
| ISSN | 0041-5782 |
| Publication status | Published - 2008 |
Bibliographical note
Keywords: Antibodies, Monoclonal; Antigens, CD3; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Immunologic Factors; Tumor Necrosis Factor-alpha
ID: 8465562